rimonabant

rimonabant

 英

  • 網絡利莫那班;供應利莫那班;鹽酸利莫那班

例句

Rimonabant is approved in Europe but has not been approved in the United States.

利莫那班已經歐洲獲得批準但是沒有美國

Rimonabant has not been approved by the US Food and Drug Administration, but is available in several other countries.

利莫尚未得到批準美國食品藥物管理局其他幾個國家

This results suggest that rimonabant (pictured) is "similar to or slightly better than existing weight-loss drugs, " they wrote.

這些結果顯示現存減肥相比作用相似稍微好些”。

The finding is the latest blow for rimonabant, which once was predicted to be a multibillion-dollar seller.

這個發現最近一次打擊曾經預計銷量數十億美元

International Circulation: The STRADIVARIUS trial failed to show an effect of rimonabant on disease progression for the primary end point.

國際循環》:STRADIVARIUS研究顯示出對于主要研究終點影響

However, the secondary endpoint, change in TAV, showed a statistically significant treatment effect favoring rimonabant.

然而中學端點改變tav顯示統計學治療效果偏袒

Rimonabant is approved in Europe but is contraindicated in patients with major depression and those taking antidepressants.

利莫那班批準歐洲而且禁忌抑郁癥患者服用抑郁

Upstairs rimonabant targets of moron I do not know what nonsense.

樓上胡言亂說什么

The method is sensitive, reproducible and adapts to the determination of rimonabant and orlistat in different weight-loss functional foods.

方法靈敏度重現性用于不同類型減肥保健食品非法添加奧利檢測

Some experts question whether rimonabant is safe for people with even mild depression.

一些專家質疑利莫那班那些甚至只是輕微抑郁癥人們是否安全

Further, rimonabant entirely blocked long-term depression by blocking TRPV1 channels.

另外通過阻斷TRPV1通道完全阻斷抑郁

One promising approach is the use of the selective cannabinoid type 1 receptor antagonist rimonabant.

一個有前途方法使用選擇性大麻1受體拮抗劑

Rimonabant belongs to the new drug class of cannabinoid-1 receptor antagonists.

利莫那班屬于藥物大麻-1受體拮抗劑

The study also confirmed a significant risk of anxiety and depression from the weight loss drug rimonabant.

項研究證實風險焦慮抑郁減肥

In addition, many kinds of anti-obesity drugs are under development(as axokine, rimonabant, topiramate).

此外多種正在開發研究減肥阿索開利莫那班)。

Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardio metabolic risk factors

利莫那班一種處理復雜心臟代謝危險因素大麻受體1阻滯劑